Skip to main content

Animations

MJFF Publications

3101 - 3110 of 6568 Results
Title
Year
  • Year
  • 2020
  • 2008
  • 2026
  • 2019
  • 2011
  • 2026
  • 2026
  • 2023
  • 2020
  • 2021
  • Summary Details
    OPEN
    Title: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28319
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Morphometric analysis of hypothalamic cells showing c-Fos proteins after movement restriction and EHF-irradiation
    Journal Name: Pathophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.pathophys.2007.11.001
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-026-01265-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Practical approaches to inclusive recruitment practices in Parkinson's disease research
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1877718x261440708
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Collaborative action for biomarker breakthroughs: Validating α-synuclein seed amplification assays in Parkinson's disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x261431949
    Citation Count: 0
  • α-synuclein seed amplification in Parkinson's disease – Authors' reply
    2023
    Summary Details
    OPEN
    Title: α-synuclein seed amplification in Parkinson's disease – Authors' reply
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-x
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Autonomic dysfunction is associated with neuropsychological impairment in Lewy body disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-020-09783-7
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Common and rare variants in HFE are not associated with Parkinson's disease in Europeans
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.019
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.